Examination of the two component conformity index formula in IMRT and 3DCRT of the prostate cancer

被引：0
|
作者：
Piotrowski, T [1 ]
机构：
[1] Univ Med Sci, Dept Electroradiol, Poznan, Poland
来源：
RADIOTHERAPY AND ONCOLOGY | 2005年 / 76卷
关键词：
D O I：
10.1016/S0167-8140(05)81006-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S23 / S24
页数：2
相关论文
共 50 条
  • [1] NTCP AND TCP COMPARISON OF 3DCRT AND IMRT+3DCRT PLANS IN RADIOTHERAPY TREATMENT OF PROSTATE CANCER
    Barbosa, B.
    Bravo, I.
    RADIOTHERAPY AND ONCOLOGY, 2011, 98 : S32 - S32
  • [2] Toxicity evaluation in adjuvant hypofractionated IMRT versus conventional 3DCRT in prostate cancer
    Russo, D.
    Leone, A.
    Papaleo, A.
    Cavalera, E.
    Di Paola, G.
    Ricci, F. P.
    Chiuri, V. E.
    Accettura, C.
    Santantonio, M.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S96 - S97
  • [3] MRI-based 3DCRT and IMRT
    Shukla, H
    Klahr, P
    Seitzer, P
    Abraham, D
    RADIOTHERAPY AND ONCOLOGY, 2003, 68 : S115 - S115
  • [4] Dose Calculation Algorithms in 3DCRT and IMRT
    Knoos, T.
    McClean, B.
    MEDICAL PHYSICS, 2008, 35 (06)
  • [5] Comparison of dose to rectum and bladder with 3DCRT and IMRT plans for the treatment of prostate
    Reddy, N
    Sood, B
    Mazur, A
    Osian, A
    Sampath, S
    Ravi, A
    Poli, J
    Nori, D
    MEDICAL PHYSICS, 2005, 32 (06) : 1964 - 1964
  • [6] Chestwall and breast immobilization for 3DCRT and IMRT
    Szabo, J.
    Kahan, Z.
    Fodor, E.
    Nagy, Z.
    Thurzo, L.
    Hideghety, K.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S434 - S434
  • [7] IMRT or 3DCRT and cardiopulmonary mortality risk in the elderly with Eeophageal cancer
    Lin, S.
    Zhang, N.
    Godby, J.
    Wang, J.
    Marsh, G.
    Liao, Z.
    Komaki, R.
    Ho, L.
    Hofstetter, W.
    Swisher, S.
    Mehran, R.
    Buchholz, T.
    Elting, L.
    Giordano, S.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S58 - S59
  • [8] A phase III protocol of androgen suppression (AS) and 3DCRT/IMRT versus AS and 3DCRT/IMRT followed by chemotherapy (CT) with docetaxel and prednisone for localized, high-risk prostate cancer (RTOG 0521)
    Sandler, Howard M.
    Hu, Chen
    Rosenthal, Seth A.
    Sartor, Oliver
    Gomella, Leonard G.
    Amin, Mahul
    Purdy, James
    Michalski, Jeff M.
    Garzotto, Mark
    Pervez, Nadeem
    Balogh, Alexander G.
    Rodrigues, George
    Souhami, Luis
    Reaume, M. Neil
    Williams, Scott G.
    Hannan, Raquibul
    Horwitz, Eric M.
    Raben, Adam
    Paulus, Rebecca
    Shipley, William U.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (18)
  • [9] A phase III protocol of androgen suppression (AS) and 3DCRT/IMRT versus AS and 3DCRT/IMRT followed by chemotherapy (CT) with docetaxel and prednisone for localized, high-risk prostate cancer (RTOG 0521).
    Sandler, Howard M.
    Hu, Chen
    Rosenthal, Seth A.
    Sartor, Oliver
    Gomella, Leonard G.
    Amin, Mahul
    Purdy, James
    Michalski, Jeff M.
    Garzotto, Mark
    Pervez, Nadeem
    Balogh, Alexander G.
    Rodrigues, George
    Souhami, Luis
    Reaume, M. Neil
    Williams, Scott G.
    Hannan, Raquibul
    Horwitz, Eric M.
    Raben, Adam
    Paulus, Rebecca
    Shipley, William U.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [10] Comparison of Conventional 3DCRT and IMRT for Craniospinal Irradiation
    Cifter, G.
    Goyal, S.
    Agdam, H.
    Sarfaraz, M.
    MEDICAL PHYSICS, 2019, 46 (06) : E643 - E643
12345